A Multi‐mechanistic Drug Release Approach in a Bead Dosage Form and In Vitro/In Vivo Correlations

References

• Uppoor V. R.S. Regulatory perspective on in vitro (dissolution) in vivo (bioavailability) correlations. J. Control. Release 2001; 72: 127–132
   PubMed Web of Science ®Google Scholar
• FDA. Guidance for Industry: Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations. 1997
   Google Scholar
• Modi N. B., Lam A., Lindemulder E., Wang B., Gupta S. K. Application of in vitro correlations (IVIVC) in setting formulation release specifications. Biopharm. Drug Dispos. 2000; 21: 321–326
   PubMed Web of Science ®Google Scholar
• Elkoshi Z. Dissolution specifications based on release rates. J. Pharm. Sci. 1999; 88(4)434–444
   PubMedGoogle Scholar
• Brockmeier D., Dengler H. J., Voegele D. In vitro—in vivo correlation of dissolution, a time scaling problem? Transformation of in vitro results to the in vivo situation, using theophylline as a practical example. Eur. J. Clin. Pharmacol. 1985; 28: 291–300
   PubMed Web of Science ®Google Scholar
• Brockmeier D. J. B. Dressman, H. LennernasThe correlation of in vitro and in vivo drug dissolution. Oral Drug Absorption, . Marcel Dekker, Inc., New York 2000; 281–305
   Google Scholar
• Kramer J. J. B. Dressman, H. LennernasIVIVC: A perspective from the workbench. Oral Drug Absorption, . Marcel Dekker, Inc., New York 2000; 307–322
   Google Scholar
• Liu Y., Schwartz J. B., Schnaare R. L. A multi‐mechanistic drug release approach in a bead dosage form and in vitro predictions. Pharm. Dev. Technol. 2003; 8(2)163–173
   PubMed Web of Science ®Google Scholar
• Liu Y., Schwartz J. B., Schnaare R. L., Sugita E. T. A multi‐mechanistic drug release approach in a bead dosage form and in vivo predictions. Pharm. Dev. Technol. 2003; 8(4)419–430
   PubMed Web of Science ®Google Scholar
• Hayashi T., Ogura T., Takagishi Y. New evaluation method for in vitro/in vivo correlation of enteric‐coated multiple unit dosage forms. Pharm. Res. 1995; 12(9)1333–1337
   PubMedGoogle Scholar
• Wagner J. G. Pharmacokinetics for the Pharmaceutical Scientist. Technomic Publishing Company, Inc., Lancaster, PA 1993
   Google Scholar
• Balan G., Timmins P., Greene D. S., Marathe P. H. In‐vitro in‐vivo correlation models for glibenclamide after administrration of metformin/glibenclamide tablets to healthy human volunteers. J. Pharm. Pharmacol. 2000; 52: 831–838
   PubMed Web of Science ®Google Scholar
• Mojaverian P., Rosen J., Vadino W. A., Liebowitz S., Radwanski E. In‐vivo/in‐vitro correlation of four extended release formulations of pseudoephedrine sulfate. J. Pharm. Biomed. Anal. 1997; 15: 439–445
   PubMed Web of Science ®Google Scholar
• Veng‐Pedersen P., Gobburu J. V.S., Meyer M. C., Straughn A. B. Carbamazepine level‐A in vivo‐in vitro correlation (IVIVC): A scaled convolution based predictive approach. Biopharm. Drug Dispos. 2000; 21: 1–6
   PubMed Web of Science ®Google Scholar
• Levy G., Hollister L. E. Inter‐ and intrasubject variations in drug absorption kinetics. J. Pharm. Sci. 1964; 53(12)1446–1452
   PubMedGoogle Scholar
• Ebel J. P., Jay M., Beihn R. M. An in vitro/in vivo correlation for the disintegration and onset of drug release from enteric‐coated pellets. Pharm. Res. 1993; 10(2)233–238
   PubMedGoogle Scholar
• Gupta P. K., Robinson J. R. A. KydonieusOral controlled‐release delivery. Treatise on Controlled Drug Delivery, . Marcel Dekker, Inc., New York 1992, 255 pp.
   Google Scholar
• Abuzarur‐Aloul R., Gjellan K., Sjolund M., Graffner C. Critical dissolution tests of oral system based on statistically designed experiments. II. In vitro optimization of screened variables on ER‐coated spheres for the establishment of an in vitro/in vivo correlation. Drug Dev. Ind. Pharm. 1998; 24(3)203–212
   PubMed Web of Science ®Google Scholar
• Pitsiu M., Sathyan G., Gupta S., Verotta D. A semiparametric deconvolution model to establish in vivo‐in vitro correlation applied to OROS oxybutynin. J. Pharm. Sci. 2001; 90(6)702–712
   PubMedGoogle Scholar
• Yu Z., Schwartz J. B., Sugita E. T. Theophylline controlled‐release formulations: In vivo‐in vitro correlations. Biopharm. Drug Dispos. 1996; 17: 259–272
   PubMed Web of Science ®Google Scholar
• Hussein Z., Friedman M. Release and absorption characteristics of novel theophylline sustained‐release formulations: in vitro‐in vivo correlation. Pharm. Res. 1990; 7(11)1167–1171
   PubMedGoogle Scholar
• Eckert T., Cordes G., Seidel R. Release of active substance from enteric‐coated gelatine capsules in vivo and in vitro. 4. Studies with the pH endo‐radio transmitter in man. Arzneim.‐Forsch. 1971; 21(9)1403–1406
   PubMedGoogle Scholar
• Rasmussen S. A comparison between the in vitro and the in vivo disintegration times of enteric‐coated tablets. J. Pharm. Sci. 1968; 57(8)1360–1363
   PubMedGoogle Scholar
• Kaniwa N., Ogata H., Aoyagi N., Koibuchi M., Shibazaki T., Ejima A., Takanashi S., Kamiyama H., Suzuki H., Hinohara Y. Bioavailability of pyridoxal phosphate from enteric‐coated tablets. III. Correlations between bioavailability in humans and beagle dogs and between bioavailability in humans and in vitro dissolution rates. Chem. Pharm. Bull. 1985; 33(9)3906–3914
   PubMedGoogle Scholar
• Cass L. J., Frederik W. S. A clinical evaluation of a sustained‐release aspirin. Curr. Ther. Res. 1965; 7(11)683–692
   PubMed Web of Science ®Google Scholar
• Rosen E., Polk A., Free S. M., Tannenbaum P. J., Crosley A. P., Jr. Comparative study in man of the absorption and excretion of amobarbital‐14C from sustained‐release and nonsustained‐release dosage forms. J. Pharm. Sci. 1967; 56(10)1285–1287
   PubMed Web of Science ®Google Scholar
• Rosen E., Ellison T., Tannenbaum P., Free S. M., Crosley A. P., Jr. Comparative study in man and dog of the absorption and excretion of dextroamphetamine‐14C sulfate in sustained‐release and nonsustained‐release dosage forms. J. Pharm. Sci. 1967; 56(3)365–369
   Web of Science ®Google Scholar
• Polli J. E. Dependence of in vitro‐in vivo correlation analysis acceptability on model selections. Pharm. Dev. Technol. 1999; 4(1)89–96
   PubMed Web of Science ®Google Scholar